SP332CIRCULATING FIBROBLAST GROWTH FACTOR-23 LEVELS ARE ASSOCIATED WITH AN INCREASED RISK OF ANEMIA DEVELOPMENT IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE | Zendy

AI Assistant Blog Pricing

SP332CIRCULATING FIBROBLAST GROWTH FACTOR-23 LEVELS ARE ASSOCIATED WITH AN INCREASED RISK OF ANEMIA DEVELOPMENT IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.